# A Study of of MORAb-004 in Subjects With Solid Tumors

> **NCT00847054** · PHASE1 · COMPLETED · sponsor: **Morphotek** · enrollment: 80 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** MORAb-004 (monoclonal antibody to TEM1)

## Key facts

- **NCT ID:** NCT00847054
- **Lead sponsor:** Morphotek
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847054, "A Study of of MORAb-004 in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00847054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*